title: 59A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 59A;pretreatment;female;breast tumor

tag: 59A;pretreatment;female;breast tumor


title: 4A;pretreatment;female;breast tumor; not assessable

status: Public on Dec 10 2007

type: RNA

city: San Diego

first: John

last: Walker

state: CA

address: 10675 John Jay Hopkins Dr

country: USA

institute: NIBR

description: breast tumor biopsy

hyb_protocol: standard Affymetrix procedures except for use of a custom 24-channel fluidics machine and GCS2500 scanner

scan_protocol: standard Affymetrix procedures

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: 4A;pretreatment;female;breast tumor

label_protocol: Approximately 500 ng of total RNA was processed to produce biotinylated cRNA targets using protocol described in Biotechniques. 2003 Mar;34(3):546-50, 552-4, 556

extract_protocol: Biopsies were snap-frozen after collection and stored in liquid nitrogen.  Frozen sections were taken prior to RNA extraction to confirm the presence of cancerous tissue within the specimens.  Only samples in which the malignant component comprised at least 20% of the section area were used in further analyses.  Immediately before RNA extraction the biopsies were pulverised using U2 micro-dismembranator U (Braun Biotech).  Total RNA was extracted from the resultant frozen tissue powder using TRI-reagent (Sigma) according to the manufacturer's recommendations.  Extracted RNA was additionally purified on RNeasy mini columns (Qiagen).  RNA quantity and quality was verified on Bioanalyser 2100 (Agilent).

tag: 4A;pretreatment;female;breast tumor


title: 53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 49A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 49A;pretreatment;female;breast tumor

tag: 49A;pretreatment;female;breast tumor


title: 48A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 48A;pretreatment;female;breast tumor

tag: 48A;pretreatment;female;breast tumor


title: 47A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 47A;pretreatment;female;breast tumor

tag: 47A;pretreatment;female;breast tumor


title: 45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 46A;pretreatment;female;breast tumor; not assessable

description: breast tumor biopsy

source_name: 46A;pretreatment;female;breast tumor

tag: 46A;pretreatment;female;breast tumor


title: 46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable

description: breast tumor biopsy


title: 44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 44A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 44A;pretreatment;female;breast tumor

tag: 44A;pretreatment;female;breast tumor


title: 42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 41A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 41A;pretreatment;female;breast tumor

tag: 41A;pretreatment;female;breast tumor


title: 39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 45A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 45A;pretreatment;female;breast tumor

tag: 45A;pretreatment;female;breast tumor


title: 38A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 38A;pretreatment;female;breast tumor

tag: 38A;pretreatment;female;breast tumor


title: 37A;pretreatment;female;breast tumor; not assessable

description: breast tumor biopsy

source_name: 37A;pretreatment;female;breast tumor

tag: 37A;pretreatment;female;breast tumor


title: 37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable

description: breast tumor biopsy


title: 42A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 42A;pretreatment;female;breast tumor

tag: 42A;pretreatment;female;breast tumor


title: 39A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 39A;pretreatment;female;breast tumor

tag: 39A;pretreatment;female;breast tumor


title: 33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 40A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 40A;pretreatment;female;breast tumor

tag: 40A;pretreatment;female;breast tumor


title: 38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 34A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 34A;pretreatment;female;breast tumor

tag: 34A;pretreatment;female;breast tumor


title: 36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 35A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 35A;pretreatment;female;breast tumor

tag: 35A;pretreatment;female;breast tumor


title: 2A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 2A;pretreatment;female;breast tumor

tag: 2A;pretreatment;female;breast tumor


title: 41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 30A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 30A;pretreatment;female;breast tumor

tag: 30A;pretreatment;female;breast tumor


title: 30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 29A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 29A;pretreatment;female;breast tumor

tag: 29A;pretreatment;female;breast tumor


title: 34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 33A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 33A;pretreatment;female;breast tumor

tag: 33A;pretreatment;female;breast tumor


title: 28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 28A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 28A;pretreatment;female;breast tumor

tag: 28A;pretreatment;female;breast tumor


title: 31A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 31A;pretreatment;female;breast tumor

tag: 31A;pretreatment;female;breast tumor


title: 27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 36A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 36A;pretreatment;female;breast tumor

tag: 36A;pretreatment;female;breast tumor


title: 27A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 27A;pretreatment;female;breast tumor

tag: 27A;pretreatment;female;breast tumor


title: 24A;pretreatment;female;breast tumor; not assessable

description: breast tumor biopsy

source_name: 24A;pretreatment;female;breast tumor

tag: 24A;pretreatment;female;breast tumor


title: 25A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 25A;pretreatment;female;breast tumor

tag: 25A;pretreatment;female;breast tumor


title: 23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable

description: breast tumor biopsy


title: 19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 21A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 21A;pretreatment;female;breast tumor

tag: 21A;pretreatment;female;breast tumor


title: 29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 20A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 20A;pretreatment;female;breast tumor

tag: 20A;pretreatment;female;breast tumor


title: 18A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 18A;pretreatment;female;breast tumor

tag: 18A;pretreatment;female;breast tumor


title: 23A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 23A;pretreatment;female;breast tumor

tag: 23A;pretreatment;female;breast tumor


title: 22A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 22A;pretreatment;female;breast tumor

tag: 22A;pretreatment;female;breast tumor


title: 17A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 17A;pretreatment;female;breast tumor

tag: 17A;pretreatment;female;breast tumor


title: 22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 19A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 19A;pretreatment;female;breast tumor

tag: 19A;pretreatment;female;breast tumor


title: 14A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 14A;pretreatment;female;breast tumor

tag: 14A;pretreatment;female;breast tumor


title: 15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 15A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 15A;pretreatment;female;breast tumor

tag: 15A;pretreatment;female;breast tumor


title: 12A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 12A;pretreatment;female;breast tumor

tag: 12A;pretreatment;female;breast tumor


title: 13A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 13A;pretreatment;female;breast tumor

tag: 13A;pretreatment;female;breast tumor


title: 11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

description: breast tumor biopsy


title: 10A;pretreatment;female;breast tumor; responder

description: breast tumor biopsy

source_name: 10A;pretreatment;female;breast tumor

tag: 10A;pretreatment;female;breast tumor


title: 16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable

description: breast tumor biopsy


title: 12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 16A;pretreatment;female;breast tumor; not assessable

description: breast tumor biopsy

source_name: 16A;pretreatment;female;breast tumor

tag: 16A;pretreatment;female;breast tumor


title: 17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: 13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: PERA/EiJ_male_hypothalamus

status: Public on Apr 27 2007

hyb_protocol: standard Affymetrix procedures except for custom GNF array washer

scan_protocol: standard Affymetrix procedures using the GeneChip 3000 scanner

organism: Mus musculus

label_protocol: cDNA synthesis and amplification employed the Affymetrix 3' IVT protocol.

extract_protocol: Hypothalamus tissue was harvested from 32 strains of mice from the Mouse Diversity Panel.  Total RNA was isolated from frozen tissue using Trizol, and cleaned up using an RNeasy kit (Qiagen).  One microgram total RNA from three separate samples was pooled and 3 ug used for cDNA synthesis and amplification.


title: CSP-inducible_plus Dox_TNF_2

status: Public on Oct 30 2007

description: HeLa cells bearing the delta CS construct were first induced with doxycycline for 17 hours and then exposed to TNF-alpha (40ng/ml).  RNA samples were collected after 6 hours

hyb_protocol: standard Affymetrix procedures

source_name: CSP-inducible_plus Dox_TNF_2

label_protocol: 5 micrograms of total RNA was processed to produce biotinylated cRNA targets using standard Affymetrix protocols

extract_protocol: Trizol followed by RNeasy cleanup

tag: CSP-inducible_plus Dox_TNF_2


title: SPRET/EiJ_male_hypothalamus


title: SEA/GnJ_male_hypothalamus


title: NOD/LtJ_male_hypothalamus


title: NZB/BINJ_male_hypothalamus


title: WSB/EiJ_male_hypothalamus


title: CSP-inducible_plus Dox_TNF_1

source_name: CSP-inducible_plus Dox_TNF_1

tag: CSP-inducible_plus Dox_TNF_1


title: CSP-inducible_plus Dox_TNF_3

source_name: CSP-inducible_plus Dox_TNF_3

tag: CSP-inducible_plus Dox_TNF_3


title: 10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: minus Dox_3

description: HeLa cells

source_name: minus Dox_3

tag: minus Dox_3


title: NZW/LacJ_male_hypothalamus


title: MSM/Ms_male_hypothalamus


title: SWR/J_male_hypothalamus


title: PL/J_male_hypothalamus


title: SM/J_male_hypothalamus


title: RIIS/J_male_hypothalamus


title: 11A;pretreatment;female;breast tumor; nonresponder

description: breast tumor biopsy

source_name: 11A;pretreatment;female;breast tumor

tag: 11A;pretreatment;female;breast tumor


title: minus Dox_2

description: HeLa cells

source_name: minus Dox_2

tag: minus Dox_2


title: plus Dox_TNF_3

description: HeLa cells were first induced with doxycycline for 17 hours and then exposed to TNF-alpha (40ng/ml).  RNA samples were collected after 6 hours

source_name: plus Dox_TNF_3

tag: plus Dox_TNF_3


title: PWK/Ph_male_hypothalamus


title: SJL/J_male_hypothalamus


title: plus Dox_TNF_2

source_name: plus Dox_TNF_2

tag: plus Dox_TNF_2


title: MOLF/EiJ_male_hypothalamus


title: plus Dox_TNF_1

source_name: plus Dox_TNF_1

tag: plus Dox_TNF_1


title: MA/MyJ_male_hypothalamus


title: minus Dox_1

description: HeLa cells

source_name: minus Dox_1

tag: minus Dox_1


title: C57BLKS/J_male_hypothalamus


title: BUB/BnJmale_hypothalamus


title: CAST/EiJ_male_hypothalamus


title: A/J_male_hypothalamus


title: DBA/2J_male_hypothalamus


title: FVB/NJ_male_hypothalamus


title: I/LnJ_male_hypothalamus


title: C57BL/6J_male_hypothalamus


title: CZECHII/EiJ_male_hypothalamus


title: JF1/Ms_male_hypothalamus


title: AKR/J_male_hypothalamus


title: C3H/HeJmale_hypothalamus


title: 129S1/SvImJ_male_hypothalamus


title: C57BL/10Jmale_hypothalamus


title: CBA/J_male_hypothalamus


title: BTBR T+ tf/J_male_hypothalamus

description: BTBR T+ tf/J_male_hypothalamus

source_name: BTBR T+ tf/J_male_hypothalamus

tag: BTBR T+ tf/J_male_hypothalamus


title: SM-J_male_hypothalamus

status: Public on Apr 18 2007

hyb_protocol: standard Affymetrix procedures using the GeneChip Fluidics Station 450

extract_protocol: Hypothalamus tissue was harvested from 32 strains of mice from the Mouse Diversity Panel.  Total RNA was isolated from frozen tissue using Trizol, and cleaned up using an RNeasy kit (Qiagen).  For the male samples, 1 ug total RNA from three separate samples was pooled and 3 ug used for cDNA synthesis and amplification.  For the female samples, 1 ug total RNA from the hypothalamus of an individual mouse was used for cDNA synthesis and amplification.


title: NZB-BlNJ_male_hypothalamus


title: C57BL-6J_male_hypothalamus


title: DBA-2J_male_hypothalamus


title: RIIIS-J_male_hypothalamus


title: C57L/J_male_hypothalamus


title: BALB/cByJ_male_hypothalamus


title: BTBR T+ tf-tf_male_hypothalamus

description: BTBR T+ tf-tf_male_hypothalamus

source_name: BTBR T+ tf-tf_male_hypothalamus

tag: BTBR T+ tf-tf_male_hypothalamus


title: AKR-J_male_hypothalamus


title: A-J_male_hypothalamus


title: NZW-LacJ_male_hypothalamus


title: BUB-BnJ_male_hypothalamus


title: BALB-cByJ_male_hypothalamus


title: 129S1-SvImJ_male_hypothalamus


title: SM/J_female_hypothalamus


title: C57BL/6J_female_hypothalamus


title: NZB/BlNJ_female_hypothalamus


title: DBA/2J_female_hypothalamus


title: NZW/LacJ_female_hypothalamus


title: BTBR T+ tf/J_female_hypothalamus

description: BTBR T+ tf/J_female_hypothalamus

source_name: BTBR T+ tf/J_female_hypothalamus

tag: BTBR T+ tf/J_female_hypothalamus


title: IMR-32_pCMV_48hr_rep 2

status: Public on Feb 22 2007

data_processing: gcRMA

extract_protocol: Human neuroblastoma cells IMR-32 (ATCC) were grown in DMEM medium supplemented with 10% FBS and treated as described above.  RNA was isolated using the RNeasy Kit from Qiagen.


title: 129S1/SvImJ_female_hypothalamus


title: CT46 Clock;liver;NONE;C57/BL6x129 mop3 KO;38585

status: Public on Feb 08 2007

description: circadian liver_ clock and wt_gcrma

hyb_protocol: standard Affymetrix procedures except for use of a custom 24-channel fluidics machine

label_protocol: Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.


title: AKR/J_female_hypothalamus


title: RIIIS/J_female_hypothalamus


title: BUB/BnJ_female_hypothalamus


title: IMR-32_pCMV-SQSTM1_48hr_rep 2


title: IMR-32_pCMV-SQSTM1_48hr_rep 1


title: BALB/cByJ_female_hypothalamus


title: IMR-32_pCMV-DPP3_48hr_rep 2


title: IMR-32_pCMV_48hr_rep 1


title: A/J_female_hypothalamus


title: CT42 Clock;liver;NONE;C57/BL6x129 mop3 KO;38582

description: circadian liver_ clock and wt_gcrma


title: CT46 Clock;liver;NONE;C57/BL6x129 mop3 KO;38584

description: circadian liver_ clock and wt_gcrma


title: CT34 Clock;liver;NONE;C57/BL6x129 mop3 KO;38574

description: circadian liver_ clock and wt_gcrma


title: CT38 Clock;liver;NONE;C57/BL6x129 mop3 KO;38580

description: circadian liver_ clock and wt_gcrma


title: CT38 Clock;liver;NONE;C57/BL6x129 mop3 KO;38581

description: circadian liver_ clock and wt_gcrma


title: CT30 Clock;liver;NONE;C57/BL6x129 mop3 KO;38573

type: mixed

description: circadian liver_ clock and wt_gcrma

molecule: other


title: CT42 Clock;liver;NONE;C57/BL6x129 mop3 KO;38583

description: circadian liver_ clock and wt_gcrma


title: CT34 Clock;liver;NONE;C57/BL6x129 mop3 KO;38575

description: circadian liver_ clock and wt_gcrma


title: IMR-32_pCMV-DPP3_48hr_rep 1


title: CT22 Clock;liver;NONE;38565

description: circadian liver_ clock and wt_gcrma

source_name: CT22 Clock;liver;NONE;38565

tag: CT22 Clock;liver;NONE;38565


title: CT22 Clock;liver;NONE;38564

description: circadian liver_ clock and wt_gcrma

source_name: CT22 Clock;liver;NONE;38564

tag: CT22 Clock;liver;NONE;38564


title: CT26 Clock;liver;NONE;C57/BL6x129 wildtype;38568

description: circadian liver_ clock and wt_gcrma


title: CT26 Clock;liver;NONE;C57/BL6x129 wildtype;38569

description: circadian liver_ clock and wt_gcrma


title: CT62;liver;NONE;C57/BL6;37467

description: Circadian Liver_48hr_gcrma


title: CT30 Clock;liver;NONE;C57/BL6x129 mop3 KO;38572

description: circadian liver_ clock and wt_gcrma


title: CT54;liver;NONE;C57/BL6;37463

description: Circadian Liver_48hr_gcrma


title: CT62;liver;NONE;C57/BL6;37468

description: Circadian Liver_48hr_gcrma


title: CT54;liver;NONE;C57/BL6;37464

description: Circadian Liver_48hr_gcrma


title: CT58;liver;NONE;C57/BL6;37465

description: Circadian Liver_48hr_gcrma


title: CT46;liver;NONE;C57/BL6;37459

description: Circadian Liver_48hr_gcrma


title: CT58;liver;NONE;C57/BL6;37466

description: Circadian Liver_48hr_gcrma


title: CT50;liver;NONE;C57/BL6;37461

description: Circadian Liver_48hr_gcrma


title: CT46;liver;NONE;C57/BL6;37460

description: Circadian Liver_48hr_gcrma


title: CT50;liver;NONE;C57/BL6;37462

description: Circadian Liver_48hr_gcrma


title: CT42;liver;NONE;C57/BL6;37457

description: Circadian Liver_48hr_gcrma


title: CT38;liver;NONE;C57/BL6;37456

description: Circadian Liver_48hr_gcrma


title: CT30;liver;NONE;C57/BL6;37452

description: Circadian Liver_48hr_gcrma


title: CT22;liver;NONE;C57/BL6;37448

description: Circadian Liver_48hr_gcrma


title: CT34;liver;NONE;C57/BL6;37453

description: Circadian Liver_48hr_gcrma


title: CT42;liver;NONE;C57/BL6;37458

description: Circadian Liver_48hr_gcrma


title: CT26;liver;NONE;C57/BL6;37449

description: Circadian Liver_48hr_gcrma


title: 3am C;Muscles;NONE;C57/BL6 clock KO;38849

description: circadian muscle_clock mutant_24hr_gcrma

extract_protocol: Tissues were collected from 5 Clock/Clock mutants at each timepoint except for 34 and 46 hours after the onset of DD, when tissues from 10 Clock/Clock mice were collected and run as independent replicates. Mice were sacrificed by cervical dislocation, and the optic nerves were severed in complete darkness; brain dissection was performed using illumination from an infrared viewer (FJW Industries, Palatine, IL). SCNs were dissected out, pooled at a density of 5 per tube in 100 ?l RNAlater (Ambion, Austin, TX), frozen on dry ice, and stored at –80?C until use.


title: CT26;liver;NONE;C57/BL6;37450

description: Circadian Liver_48hr_gcrma


title: CT34;liver;NONE;C57/BL6;37454

description: Circadian Liver_48hr_gcrma


title: CT30;liver;NONE;C57/BL6;37451

description: Circadian Liver_48hr_gcrma


title: CT22;liver;NONE;C57/BL6;37447

description: Circadian Liver_48hr_gcrma


title: 7pm B;Muscles;NONE;C57/BL6 clock KO;38846


title: CT18;liver;NONE;C57/BL6;37445

description: Circadian Liver_48hr_gcrma


title: CT18;liver;NONE;C57/BL6;37446

description: Circadian Liver_48hr_gcrma


title: 3pm B;Muscles;NONE;C57/BL6 clock KO;38844


title: 11pm B;Muscles;NONE;C57/BL6 clock KO;38848


title: 3am D;Muscles;NONE;C57/BL6 clock KO;38850


title: 7pm A;Muscles;NONE;C57/BL6 clock KO;38845


title: 11pm A;Muscles;NONE;C57/BL6 clock KO;38847


title: 3pm A;Muscles;NONE;C57/BL6 clock KO;38843


title: CT38;liver;NONE;C57/BL6;37455

description: Circadian Liver_48hr_gcrma


title: 11am B;Muscles;NONE;C57/BL6 clock KO;38842


title: 11am A;Muscles;NONE;C57/BL6 clock KO;38841


title: CT58A;skeletal muscle;NONE;C57/BL6;30537

description: Circadian muscle48hr_gcrma


title: CT54A;skeletal muscle;NONE;C57/BL6;30535

description: Circadian muscle48hr_gcrma


title: CT62B;skeletal muscle;NONE;C57/BL6;30540

description: Circadian muscle48hr_gcrma


title: CT54B;skeletal muscle;NONE;C57/BL6;30536

description: Circadian muscle48hr_gcrma


title: CT50A;skeletal muscle;NONE;C57/BL6;30533

description: Circadian muscle48hr_gcrma


title: CT46B;skeletal muscle;NONE;C57/BL6;30532

description: Circadian muscle48hr_gcrma


title: 7am A;Muscles;NONE;C57/BL6 clock KO;38839


title: CT58B;skeletal muscle;NONE;C57/BL6;30538

description: Circadian muscle48hr_gcrma


title: 3am A;Muscles;NONE;C57/BL6 clock KO;38837


title: CT62A;skeletal muscle;NONE;C57/BL6;30539

description: Circadian muscle48hr_gcrma


title: CT50B;skeletal muscle;NONE;C57/BL6;30534

description: Circadian muscle48hr_gcrma


title: 3am B;Muscles;NONE;C57/BL6 clock KO;38838


title: 7am B;Muscles;NONE;C57/BL6 clock KO;38840


title: CT42A;skeletal muscle;NONE;C57/BL6;30529

description: Circadian muscle48hr_gcrma


title: CT38B;skeletal muscle;NONE;C57/BL6;30528

description: Circadian muscle48hr_gcrma


title: CT46A;skeletal muscle;NONE;C57/BL6;30531

description: Circadian muscle48hr_gcrma


title: CT34B;skeletal muscle;NONE;C57/BL6;30526

description: Circadian muscle48hr_gcrma


title: CT30B;skeletal muscle;NONE;C57/BL6;30524

description: Circadian muscle48hr_gcrma


title: CT42B;skeletal muscle;NONE;C57/BL6;30530

description: Circadian muscle48hr_gcrma


title: CT26A;skeletal muscle;NONE;C57/BL6;30521

description: Circadian muscle48hr_gcrma


title: CT26B;skeletal muscle;NONE;C57/BL6;30522

description: Circadian muscle48hr_gcrma


title: CT22B;skeletal muscle;NONE;C57/BL6;30520

description: Circadian muscle48hr_gcrma


title: CT38A;skeletal muscle;NONE;C57/BL6;30527

description: Circadian muscle48hr_gcrma


title: CT30A;skeletal muscle;NONE;C57/BL6;30523

description: Circadian muscle48hr_gcrma


title: CT34A;skeletal muscle;NONE;C57/BL6;30525

description: Circadian muscle48hr_gcrma


title: PP-2 48 hr 1

status: Public on Feb 07 2007

description: PP-2 48 hr

hyb_protocol: hybridization followed standard Affymetrix protocols while array washing used a GNF custom machine

source_name: PP-2 48 hr

extract_protocol: Normal human epidermal keratinocytes (NHEKs) were treated with DMSO or 9 (alias PP-2) (0.5 uM) and harvested at 12, 24, 36 and 48 h. Total RNA from each sample was isolated and purified with the RNeasy Mini Kit (Qiagen). Total RNA was examined on an Agilent Bioanalyzer and the 28S/18S ratio exceeded 2.0 for all samples.

tag: PP-2 48 hr


title: PP-2 36 hr 1

description: PP-2 36 hr

source_name: PP-2 36 hr

tag: PP-2 36 hr


title: CT18A;skeletal muscle;NONE;C57/BL6;30517

description: Circadian muscle48hr_gcrma


title: PP-2 24 hr 1

description: PP-2 24 hr

source_name: PP-2 24 hr

tag: PP-2 24 hr


title: PP-2 48 hr 2

description: PP-2 48 hr


title: CT18B;skeletal muscle;NONE;C57/BL6;30518

description: Circadian muscle48hr_gcrma


title: CT22A;skeletal muscle;NONE;C57/BL6;30519

description: Circadian muscle48hr_gcrma


title: DMSO 48 hr 2

description: DMSO 48 hr

source_name: DMSO 48 hr

tag: DMSO 48 hr


title: DMSO 36 hr 2

description: DMSO 36 hr

source_name: DMSO 36 hr

tag: DMSO 36 hr


title: PP-2 24 hr 2

description: PP-2 24 hr


title: DMSO 24 hr 2

description: DMSO 24 hr

source_name: DMSO 24 hr

tag: DMSO 24 hr


title: PP-2 36 hr 2

description: PP-2 36 hr


title: DMSO 48 hr 1

description: DMSO 48 hr


title: DMSO 24 hr 1

description: DMSO 24 hr


title: PP-2 12 hr 2

description: PP-2 12 hr

source_name: PP-2 12 hr

tag: PP-2 12 hr


title: DMSO 12 hr 2

description: DMSO 12 hr

source_name: DMSO 12 hr

tag: DMSO 12 hr


title: PP-2 12 hr 1

description: PP-2 12 hr


title: DMSO O hr 2

description: DMSO O hr

source_name: DMSO O hr

tag: DMSO O hr


title: DMSO 36 hr 1

description: DMSO 36 hr


title: DMSO O hr 1

description: DMSO O hr


title: DMSO 12 hr 1

description: DMSO 12 hr


title: 12h control (2);HT-29;colon:carcinoma;NONE;42995

status: Public on Feb 08 2006

description: 12h control (2)

label: 12h control (2)


title: 12h UV-50 (1);HT-29;colon:carcinoma;UV_50 J/m2;43000

description: 12h UV-50 (1)


title: 12h UV-200 (2);HT-29;colon:carcinoma;UV_200 J/m2;43003

description: 12h UV-200 (2)


title: 12h heat shock (1);HT-29;colon:carcinoma;heat shock_1hr;42998

description: 12h heat shock (1)

label: 12h heat shock (1)


title: 12h H2O2 (2);HT-29;colon:carcinoma;Hydrogen peroxide;42997

description: 12h H2O2 (2)


title: 6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24724

description: 6 h-apra-10 nM

data_processing: Rosetta Resolver intensity value

tag: 6 h-apra-10 nM


title: 6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24723

description: 6 h-apra-10 nM


title: 6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24721

description: 6 h-apra-2 nM

tag: 6 h-apra-2 nM


title: 6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24722

description: 6 h-apra-2 nM


title: 12h heat shock (2);HT-29;colon:carcinoma;heat shock_1hr;42999

description: 12h heat shock (2)

label: 12h heat shock (2)


title: 12 h-control (EtOH);HT-29;colorectal adenocarcinoma;Eth;24726

description: 12 h-control (EtOH)

tag: 12 h-control (EtOH)


title: 12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24727

description: 12 h-apra-2 nM

tag: 12 h-apra-2 nM


title: 12 h-control (EtOH);HT-29;colorectal adenocarcinoma;Eth;24725

description: 12 h-control (EtOH)


title: 12h H2O2 (1);HT-29;colon:carcinoma;Hydrogen peroxide;42996

description: 12h H2O2 (1)


title: 12h UV-50 (2);HT-29;colon:carcinoma;UV_50 J/m2;43001

description: 12h UV-50 (2)


title: 3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24718

description: 3 h-apra-10 nM

tag: 3 h-apra-10 nM


title: 12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24730

description: 12 h-apra-10 nM

tag: 12 h-apra-10 nM


title: 3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24716

description: 3 h-apra-2 nM

tag: 3 h-apra-2 nM


title: 12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24729

description: 12 h-apra-10 nM


title: 12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24728

description: 12 h-apra-10 nM


title: 6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24720

description: 6 h-control (EtOH)

tag: 6 h-control (EtOH)


title: 3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24715

description: 3 h-apra-2 nM


title: 3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24717

description: 3 h-apra-10 nM


title: 6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24719

description: 6 h-control (EtOH)


title: 3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24714

description: 3 h-apra-2 nM


title: naive TCR1;CD8+T cells;NONE;C57/BL6,gag-specific TCR;29779

status: Public on Jan 01 2006

description: naive TCR1

data_processing: Rosetta Resolver

label_protocol: samples were split into equal aliquots of ~50ng of total RNA, and used for three rounds of cDNA synthesis and cRNA amplification, as previously described (Scherer, A. et al. Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies. Biotechniques 34, 546-50, 552-4, 556 (2003).)

extract_protocol: Rag-/- TCR mice were immunized twice with 5x106 irradiated FBL and 10 µg anti-CD40 (Immunex, Seattle, WA) and 30 days later spleens from immunized Rag-/- TCR and non-immunized Rag-/- TCR and TCRxGag were removed.  Naïve CD44low and CD44high memory and tolerant CD8+ T cells were isolated by cell sorting on a FACSAria (Becton Dickinson, San Jose, CA).  RNA was extracted from sorted T cells using Trizol® Reagent (Invitrogen, Carlsbad, CA) and then purified further using an RNeasy cleanup kit from Qiagen (Valencia, CA) according to manufacturer’s protocol.  Total RNA was quantified using RiboGreen (Molecular Probes, Eugene, Oregon)


title: C406A, no treatment;whole organism;NONE;TFIIH mutant C4;37672

status: Public on Apr 20 2005

description:
no treatment
Keywords = C406A, no treatment

organism: Saccharomyces cerevisiae

source_name: yeast


title: tolerant TCR2;CD8+, tolerant;NONE;C57/BL6,gag-specific ;29784

description: tolerant TCR2


title: C403A, MMS;whole organism;MMS;TFIIH mutant C403A;37670

description:
methyl methanesulfonate (MMS) treatment was 0.03% for 30 minutes
Keywords = C403A, MMS


title: C406A, no treatment;whole organism;NONE;TFIIH mutant C4;37671


title: C403A, no treatment;whole organism;NONE;TFIIH mutant C4;37668

description:
no treatment
Keywords = C403A, no treatment


title: C403A, MMS;whole organism;MMS;TFIIH mutant C403A;37669


title: C403A, no treatment;whole organism;NONE;TFIIH mutant C4;37667


title: C406A, MMS;whole organism;MMS;TFIIH mutant C406A;37674

description:
methyl methanesulfonate (MMS) treatment was 0.03% for 30 minutes
Keywords = C406A, MMS


title: 3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24713

description: 3 h-control (EtOH)

tag: 3 h-control (EtOH)


title: wt, MMS;whole organism;MMS;wildtype;37666

description:
methyl methanesulfonate (MMS) treatment was 0.03% for 30 minutes
Keywords = wt, MMS


title: C406A, MMS;whole organism;MMS;TFIIH mutant C406A;37673


title: 12h control (1);HT-29;colon:carcinoma;NONE;42994

description: 12h control (1)

label: 12h control (1)


title: wt, no treatment;whole organism;NONE;wildtype;37663

description:
no treatment
Keywords = wt, no treatment


title: naive TCR2;CD8+T cells;NONE;C57/BL6,gag-specific TCR;29780

description: naive TCR2


title: tolerant TCR1;CD8+, tolerant;NONE;C57/BL6,gag-specific ;29783

description: tolerant TCR1


title: memory TCR2;CD8+, memory;NONE;C57/BL6,gag-specific TCR;29782

description: memory TCR2


title: wt, MMS;whole organism;MMS;wildtype;37665


title: wt, no treatment;whole organism;NONE;wildtype;37664


title: BXD 28_M7SS02080624

status: Public on Dec 02 2004

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD28 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD28
Keywords = a cross of C57BL/6 and DBA/2 mice

source_name: hematopoietic stem cells, stem cells:Lin-Sca+kit+


title: BXD 14_M7SS02080622

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD14 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD14
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 28_M7SS02080623


title: BXD 5_M7SS02080620

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD5 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD5
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 14_M7SS02080621


title: BXD 5_M7SS02080619


title: BXD 34_M7SS02080617

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD34 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD34
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 16_M7SS02080614

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD16 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD16
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 39_M7SS02080610

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD39 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD39
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 1_M7SS02080616

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD1 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD1
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 34_M7SS02080618


title: BXD 2_M7SS02080612

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD2 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD2
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 2_M7SS02080611


title: BXD 16_M7SS02080613


title: BXD 19_M7SS02080606

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD19 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD19
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 19_M7SS02080605


title: BXD 21_M7SS02080604

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD21 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD21
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD42_M7SS02042217

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD42 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD42
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 18_M7SS02080602

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD18 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD18
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD32_M7SS02042220

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD32 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD32
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD38_M7SS02042213

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD38 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD38
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 1_M7SS02080615


title: BXD38_M7SS02042214


title: memory TCR1;CD8+, memory;NONE;C57/BL6,gag-specific TCR;29781

description: memory TCR1


title: BXD 39_M7SS02080609


title: BXD 18_M7SS02080601


title: BXD 21_M7SS02080603


title: BXD 9_M7SS02080607

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD9 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD9
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD 9_M7SS02080608


title: BXD40_M7SS02042216

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD40 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD40
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD40_M7SS02042215


title: BXD42_M7SS02042218


title: BXD33_M7SS02042212

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD33 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD33
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD32_M7SS02042219


title: BXD11_M7SS02042206

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD11 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD11
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD33_M7SS02042211


title: BXD8_M7SS02042204

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD8 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD8
Keywords = a cross of C57BL/6 and DBA/2 mice


title: 3AJZ02072561_OlfactoryBulb

status: Public on Mar 19 2004

description: OlfactoryBulb

label_protocol: Five micrograms of total RNA was used to synthesize cDNA that was then used as a template to generate biotinylated cRNA using Enzo kits.

extract_protocol: Human tissue samples were obtained from several sources: Clinomics Biosciences (Pittsfield, MA), Clontech, AllCells (Berkeley, CA), Clonetics/BioWhittaker (Walk-ersville, MD), AMS Biotechnology (Abingdon, Oxfordshire, U.K.), and the University of California at San Diego. When samples from four or more subjects were available, equal numbers of male and female subjects were used to make two independent pools; when fewer than four samples were available, RNA samples were pooled, and duplicate amplifications were performed for each pool (detailed annotation for human samples is on our web site, http:\\symatlas.gnf.org)  Extracted RNA was additionally purified on RNeasy mini columns (Qiagen).  RNA quantity and quality was verified on Bioanalyser 2100 (Agilent).


title: BXD31_M7SS02042209

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD31 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD31
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD11_M7SS02042205


title: BXD12_M7SS02042207

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD12 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD12
Keywords = a cross of C57BL/6 and DBA/2 mice


title: BXD12_M7SS02042208


title: BXD8_M7SS02042203


title: 3AJZ02081478a_Superior_Cervical_Ganglion


title: 3AJZ02083089a_Uterus_Corpus


title: BXD6_M7SS02042202

description:
Bone marrow from female BXD recombinant inbred mice between 3 and 6 months of age were flushed from the femurs and tibiae of three mice and pooled, for each sample. After standard erythrocyte lysis nucleated cells were were stained with a panel of biotinylated lineage-specific antibodies (Mouse Lineage Panel, containing anti-CD3e, anti-CD45R/B220, anti-CD11b (Mac-1), anti-TER119 (Ly-76), anti-Gr-1 (Ly-6G), Pharmingen, San Diego, CA), FITC-anti-Sca-1 and APC-anti-c-kit (Pharmingen).  Stem cell yield across all BXD samples varied from 16,000 to 118,000 Lin-Sca-1+ c-kit+ cells.  Cells were washed twice, and incubated for 30 minutes with streptavidin-PE (Pharmingen). After two washes cells were resuspended in PBS with 0,2% BSA, and purified using a MoFlo flowcytometer. The lineage-depleted bone marrow cell population was defined as the 5% cells showing least PE-fluorescence intensity. Cells was immediately collected in RNA lysis buffer.
This sample is from recombinant inbred strain BXD6 ; a cross of C57BL/6 and DBA/2 mice
Keywords = This sample is from recombinant inbred strain BXD6
Keywords = a cross of C57BL/6 and DBA/2 mice


title: 3AJZ02083092a_Skeletal_Muscle_Psoas


title: BXD31_M7SS02042210


title: 3AJZ02060514_OlfactoryBulb

description: OlfactoryBulb


title: 3AJZ02022867_Pituitary

description: Pituitary


title: 3ARS02080736e_DRG

description: DRG


title: 3AJZ02082987B_TONGUE

description: TONGUE


title: 3AJZ02081478b_Superior_Cervical_Ganglion


title: BXD6_M7SS02042201


title: 3ARS02080736f_DRG

description: DRG


title: 3ARS02080772a_atrioventricular_node


title: 3AJZ02083089b_Uterus_Corpus


title: 3AJZ02081483b_Trigeminal_Ganglion


title: 3AJZ02030476_pituitary

description: pituitary


title: 3ARS02080772b_atrioventricular_node


title: 3AJZ02083092b_Skeletal_Muscle_Psoas


title: 3AJZ02082987A_TONGUE

description: TONGUE


title: 3ARS02080773a_ciliary_ganglion


title: 3ARS02080776b_skin

description: skin


title: 3ARS02080773b_ciliary_ganglion


title: 3AJZ02081483a_Trigeminal_Ganglion


title: 3ARS02080776a_skin

description: skin


title: 3AJZ02081482b_Appendix

description: Appendix


title: 3AJZ02050806_Ovary

description: Ovary


title: 3AJZ02051002_AdrenalCortex

description: AdrenalCortex


title: 3AJZ02022639_trachea

description: trachea


title: 3AJZ02041226_salivarygland

description: salivarygland


title: 3AJZ02081482a_Appendix

description: Appendix


title: 3AJZ02022756_trachea

description: trachea


title: 3AJZ02040823_salivarygland

description: salivarygland


title: 3AJZ02052305_TestiIntersitial

description: TestiIntersitial


title: 3AJZ02052112_TestiLeydigCell

description: TestiLeydigCell


title: 3AJZ02052302_Ovary

description: Ovary


title: 3AJZ02051707_Testi_GermCell


title: 3AJZ02050802_AdrenalCortex

description: AdrenalCortex


title: 3AJZ02060502_Pancreas

description: Pancreas


title: 3AJZ02051709_Testi_Intersitial


title: 3AJZ02060417_IsletCell

description: IsletCell


title: 3AJZ02051713_Testi_SeminiferousTubule


title: 3AJZ02052309_Islet

description: Islet


title: 3AJZ02022752_testis

description: testis


title: 3AJZ02052108_Testi-GermCell

description: Testi-GermCell


title: 3AJZ02072570_HUMANCULTUREDADIPOCYTE

description: HUMANCULTUREDADIPOCYTE


title: 3AJZ02052114_TestiSeminiferousTubule

description: TestiSeminiferousTubule


title: 3AJZ02022635_testis

description: testis


title: 3AJZ02060401_Pancreas

description: Pancreas


title: 3AJZ02051711_Testi_LeydigCell


title: 3AJZ02053101_HBEC

description: HBEC


title: 3AJZ02053103_HBEC

description: HBEC


title: 3AJZ02052312_HUMANCULTUREDADIPOCYTE

description: HUMANCULTUREDADIPOCYTE


title: 3AJZ02060603_SmoothMuscle

description: SmoothMuscle


title: 3AJZ02053107_CardiacMyocytes

description: CardiacMyocytes


title: 3AJZ02060604_CardiacMyocytes

description: CardiacMyocytes


title: 3ARS0207253IA_PLACENTA

description: PLACENTA


title: 3AJZ02052323_FETALTHYROID

description: FETALTHYROID


title: 3AMH02022604_Thyroid

description: Thyroid


title: 3AMH02030703_Uterus

description: Uterus


title: 3AMH02022204_Thyroid

description: Thyroid


title: 3AJZ02022643_kidney

description: kidney


title: 3ARS0207263HB_PLACENTA

description: PLACENTA


title: 3AJZ02052217_fetalThyroid

description: fetalThyroid


title: 3AMH02030704_Prostate

description: Prostate


title: 3AJZ02021913_ UTERUS

description: UTERUS


title: 3AJZ02053105_SmoothMuscle

description: SmoothMuscle


title: 3AJZ02022760_kidney

description: kidney


title: 3AMH02030702_Heart

description: Heart


title: 3AMH02030706_Liver

description: Liver


title: 3AJZ02021915_ LIVER

description: LIVER


title: 3AMH02030705_Lung

description: Lung


title: 3AJZ02022872_ fetal lung

description: fetal lung

source_name: 3AJZ02022872_ fetal lung

tag: 3AJZ02022872_ fetal lung


title: 3AJZ02022762_adrenal gland

description: adrenal gland

source_name: 3AJZ02022762_adrenal gland

tag: 3AJZ02022762_adrenal gland


title: 3AJZ02022645_adrenal gland

description: adrenal gland

source_name: 3AJZ02022645_adrenal gland

tag: 3AJZ02022645_adrenal gland


title: 3AJZ02031304_fetallung

description: fetallung


title: 3AJZ02022111_ fetal brain

description: fetal brain

source_name: 3AJZ02022111_ fetal brain

tag: 3AJZ02022111_ fetal brain


title: 3AJZ02021909_HEART

description: HEART


title: 3AJZ02022228_ fetal brain

description: fetal brain

source_name: 3AJZ02022228_ fetal brain

tag: 3AJZ02022228_ fetal brain


title: 3AJZ02022224_  spinal cord

description: spinal cord

source_name: 3AJZ02022224_  spinal cord

tag: 3AJZ02022224_  spinal cord


title: 3AJZ02022107_  spinal cord

description: spinal cord

source_name: 3AJZ02022107_  spinal cord

tag: 3AJZ02022107_  spinal cord


title: 3AJZ02081480b_Pons

description: Pons


title: 3AJZ02060508_CingulateCortex

description: CingulateCortex


title: 3AJZ02021911_ PROSTATE

description: PROSTATE

source_name: 3AJZ02021911_ PROSTATE

tag: 3AJZ02021911_ PROSTATE


title: 3ARS02080777b_subthalamic_nucleus


title: 3AJZ02081480a_Pons

description: Pons


title: 3AJW02021805_lung

description: lung


title: 3AJZ02060407_CingulateCortex

description: CingulateCortex


title: 3AJZ02040819_brainThalamus

description: brainThalamus


title: 3AJZ02031306_brainThalamus

description: brainThalamus


title: 3AJZ02061907_Hypothalamus

description: Hypothalamus


title: 3AJZ02060506_Hypothalamus

description: Hypothalamus


title: 3ARS02080777a_subthalamic_nucleus


title: 3AJZ02053109_PrefrontalCortex

description: PrefrontalCortex


title: 3AJZ02062605_OccipitalLobe

description: OccipitalLobe


title: 3AMH02022205_Brain Amygdala

description: Brain Amygdala

source_name: 3AMH02022205_Brain Amygdala

tag: 3AMH02022205_Brain Amygdala


title: 3AJZ02052306_OccipitalLobe

description: OccipitalLobe


title: 3AJZ02053111_PrefrontalCortex

description: PrefrontalCortex


title: 3AMH02022605_Brain Amygdala

description: Brain Amygdala

source_name: 3AMH02022605_Brain Amygdala

tag: 3AMH02022605_Brain Amygdala


title: 3AJZ02081479b_Medulla_Oblongata


title: 3AJZ02022764_cerebellum

description: cerebellum


title: 3AJZ02031410_wholebrain

description: wholebrain


title: 3AJZ02022226_  brain, caudate nucleus

description: brain, caudate nucleus

source_name: 3AJZ02022226_  brain, caudate nucleus

tag: 3AJZ02022226_  brain, caudate nucleus


title: 3AJZ02030474_bonemarrow

description: bonemarrow


title: 3AJZ02061902_CerebellumPeduncles

description: CerebellumPeduncles


title: 3AJZ02081484b_TemporalLobe

description: TemporalLobe


title: 3AMH02030701_Whole Brain

description: Whole Brain

source_name: 3AMH02030701_Whole Brain

tag: 3AMH02030701_Whole Brain


title: 3ARS02080774b_globus_pallidus


title: 3AJZ02022870_  brain, caudate nucleus

description: brain, caudate nucleus

source_name: 3AJZ02022870_  brain, caudate nucleus

tag: 3AJZ02022870_  brain, caudate nucleus


title: 3AJZ02022647_cerebellum

description: cerebellum


title: 3AJZ02081484a_TemporalLobe

description: TemporalLobe


title: 3AJZ02051604_CerebellumPeduncles

description: CerebellumPeduncles


title: 3AJZ02022865_bone marrow

description: bone marrow

source_name: 3AJZ02022865_bone marrow

tag: 3AJZ02022865_bone marrow


title: 3AJZ02081479a_Medulla_Oblongata


title: 3ARS02080774a_globus_pallidus


title: 3AMH02082802_BM_CD71EarlyErythroid

description: bone marrow-CD71EarlyErythroid


title: 3AJZ02051605_ParietalLobe

description: ParietalLobe


title: 3AMH02082801_BM_CD71EarlyErythroid

description: bone marrow-CD71EarlyErythroid


title: 3AJZ02022115_  lymph node

description: lymph node

source_name: 3AJZ02022115_  lymph node

tag: 3AJZ02022115_  lymph node


title: 3AJZ02052116_Tonsil

description: Tonsil


title: 3AJZ02022750_fetal liver

description: fetal liver

source_name: 3AJZ02022750_fetal liver

tag: 3AJZ02022750_fetal liver


title: 3AJZ02022222_  leukemia, chronic Myelogenous K-562

description: leukemia, chronic Myelogenous K-562


title: 3AJZ02031411_thymus

description: thymus


title: 3AJZ02022232_  lymph node

description: lymph node

source_name: 3AJZ02022232_  lymph node

tag: 3AJZ02022232_  lymph node


title: 3AJZ02022758_thymus

description: thymus


title: 3AJZ02051715_Tonsil

description: Tonsil


title: 3AJZ02022633_fetal liver

description: fetal liver

source_name: 3AJZ02022633_fetal liver

tag: 3AJZ02022633_fetal liver


title: 1BJZ02061809_pituitary

description: pituitary


title: 3AJZ02022105_  leukemia, chronic Myelogenous K-562

description: leukemia, chronic Myelogenous K-562


title: 3AJZ02031099_ lymphomaburkittsDaudi

description: lymphomaburkittsDaudi

source_name: 3AJZ02031099_ lymphomaburkittsDaudi

tag: 3AJZ02031099_ lymphomaburkittsDaudi


title: 3AJZ02031302_lymphomaburkittsDaudi

description: lymphomaburkittsDaudi


title: 1BJZ02061909_pituitary

description: pituitary


title: 3AJZ02022103_leukemia, promyelocytic-HL-60

description: leukemia, promyelocytic-HL-60


title: 3AJZ02022220_leukemia, promyelocytic-HL-60

description: leukemia, promyelocytic-HL-60


title: 3AJZ02051606_ParietalLobe

description: ParietalLobe


title: 1BJZ022987B_TONGUE

description: TONGUE


title: 1BJZ02060414_OlfactoryBulb

description: OlfactoryBulb


title: 3AMH02022603_LymphomaRaji

description: LymphomaRaji


title: 1BJZ02060511_OlfactoryBulb

description: OlfactoryBulb


title: 3AMH02082810_721_BLymphoblasts


title: 1BJZ022987A_TONGUE

description: TONGUE


title: 3AMH02082809_721_BLymphoblasts


title: 1BJZ02083089b_Uterus_Corpus


title: 1BJZ02081478b_Superior_Cervical_Ganglion


title: 1BRS02081536f_DRG

description: DRG


title: 1BJZ02081478a_Superior_Cervical_Ganglion


title: 3AMH02082102_BM_CD34

description: bone marrow-CD34


title: 3AJZ02022218_leukemia lymphoblastic (MOLT-4)

description: leukemia lymphoblastic (MOLT-4)


title: 3AMH02082001_BM_CD34

description: bone marrow-CD34


title: 1BJZ02083092b_Skeletal_Muscle_Psoas


title: 3AJZ02022869_leukemia lymphoblastic (MOLT-4)

description: leukemia lymphoblastic (MOLT-4)


title: 3AMH02082103_BM_CD105Endothelial

description: bone marrow-CD105Endothelial


title: 1BJZ02083092a_Skeletal_Muscle_Psoas


title: 3AMH02082108_PB_CD19BCells

description: peripheral blood-CD19BCells


title: 3AMH02082104_BM_CD105Endothelial

description: bone marrow-CD105Endothelial


title: 3AMH02030602_LymphomaRaji

description: LymphomaRaji


title: 1BRS02081536e_DRG

description: DRG


title: 3AMH02082107_PB_CD19BCells

description: peripheral blood-CD19BCells


title: 1BJZ02083089a_Uterus_Corpus


title: 1BRS02080872a_atrioventricular_node


title: 1BRS02080872b_atrioventricular_node


title: 1BJZ02081483b_Trigeminal_Ganglion


title: 3AMH02082805_PB_CD8TCells

description: peripheral blood-CD8TCells


title: 1BRS02080873b_ciliary_ganglion


title: 3AMH02082803_PB_CD4TCells

description: peripheral blood-CD4TCells


title: 3AMH02082806_PB_CD8TCells

description: peripheral blood-CD8TCells


title: 1BJZ02081483a_Trigeminal_Ganglion


title: 3AMH02082804_PB_CD4TCells

description: peripheral blood-CD4TCells


title: 1BRS02080876b_skin

description: skin


title: 3AMH02082110_PB_CD56NKCells

description: peripheral blood-CD56NKCells


title: 3AMH02082109_PB_CD56NKCells

description: peripheral blood-CD56NKCells


title: 1BRS02080876a_skin

description: skin


title: 3AMH02082012_PB_BDCA4DentriticCells

description: peripheral blood-BDCA4DentriticCells


title: 1BRS02080873a_ciliary_ganglion


title: 1BJZ02052208_Ovary

description: Ovary


title: 1BJZ02081482a_Appendix

description: Appendix


title: 1BJZ02081482b_Appendix

description: Appendix


title: 3AMH02082316_PB_CD14Monocytes

description: peripheral blood-CD14Monocytes


title: 1BJZ02052201_AdrenalCortex

description: AdrenalCortex


title: 1BJZ02050813_Ovary

description: Ovary


title: 1BJZ02022755_trachea

description: trachea


title: 3AJZ02052318_WHOLEBLOOD(JJV)

description: WHOLEBLOOD


title: 3AMH02082106_BM_CD33Myeloid

description: bone marrow-CD33Myeloid


title: 1BJZ02022640_trachea

description: trachea


title: 3AMH02082111_PB_BDCA4DentriticCells

description: peripheral blood-BDCA4DentriticCells


title: 1BJZ02050809_AdrenalCortex

description: AdrenalCortex


title: 1BJZ02041227_salivarygland

description: salivarygland


title: 3AJZ02052320_WHOLEBLOOD(JJV)

description: WHOLEBLOOD


title: 3AMH02082105_BM_CD33Myeloid

description: bone marrow-CD33Myeloid


title: 3AMH02082315_PB_CD14Monocytes

description: peripheral blood-CD14Monocytes


title: 3AMH02022201_Colorectal Adenocarc

description: Colorectal Adenocarc

source_name: 3AMH02022201_Colorectal Adenocarc

tag: 3AMH02022201_Colorectal Adenocarc


title: 1BJZ02040822_salivarygland

description: salivarygland


title: 1BJZ02052113_TestiSeminiferousTubule

description: TestiSeminiferousTubule


title: 3AMH02030601_Colorectal Adenocarcinoma

description: Colorectal Adenocarcinoma

source_name: 3AMH02030601_Colorectal Adenocarcinoma

tag: 3AMH02030601_Colorectal Adenocarcinoma


title: 1BJZ02052109_TestiIntersitial

description: TestiIntersitial


title: 1BJZ02051714_Testi_SeminiferousTubule


title: MGJZ030207135Btestis

description: testis


title: MGJZ030207135Atestis

description: testis


title: MGMH030212060Apancreas

description: pancreas


title: 1BJZ02052107_TestiGermCell

description: TestiGermCell


title: 1BJZ02052111_TestiLeydigCell

description: TestiLeydigCell


title: 1BJZ02051708_Testi_GermCell


title: 1BJZ02051710_Testi_Intersitial


title: 1BJZ02022751_testis

description: testis


title: MGMH030212060Bpancreas

description: pancreas


title: 1BJZ02051712_Testi_LeydigCell


title: 1BJZ02022636_testis

description: testis


title: 1BJZ02060515_IsletCell

description: IsletCell


title: MGMH030402089Boocyte

description: oocyte


title: 1BMH02022702_Pancreas

description: Pancreas


title: MGMH030228088Bfertilizedegg

description: fertilized egg


title: 1BJZ02052308_Islet

description: Islet


title: MGMH030228089Aoocyte

description: oocyte


title: MGMH030212037Athyroid

description: thyroid


title: MGJZ030211018Bliver

description: liver


title: MGJZ030211018Aliver

description: liver


title: MGMH030212037Bthyroid

description: thyroid


title: MGJZ030212027Bsalivarygland

description: salivary gland


title: MGMH030228088Afertilizedegg

description: fertilized egg


title: 1BJZ02060501_Pancreas

description: Pancreas


title: 1BJZ02053104_HBEC

description: HBEC


title: 1BJZ02052313_HUMANCULTUREDADIPOCYTE

description: HUMANCULTUREDADIPOCYTE


title: MGJZ030212027Asalivarygland

description: salivary gland


title: MGMH030212051Asmallintestine

description: small intestine; duodenum


title: 1BJZ02052311_HUMANCULTUREDADIPOCYTE

description: HUMANCULTUREDADIPOCYTE


title: MGJZ030211016Bkidney

description: kidney


title: MGMH030212051Bsmallintestine

description: small intestine; duodenum


title: 1BJZ02053102_HBEC

description: HBEC


title: 1BJZ02060601_SmoothMuscle

description: SmoothMuscle


title: MGMH030312016Akidney

description: kidney


title: 1BJZ02053106_SmoothMuscle

description: SmoothMuscle


title: 1BJZ02053108_CardiacMyocytes

description: CardiacMyocytes


title: 1BJZ02061205_fetalThyroid

description: fetalThyroid


title: 1BRS0207253HB_PLACENTA

description: PLACENTA


title: 1BJZ02022114_fetallung

description: fetallung


title: 1BRS0207253IB_PLACENTA

description: PLACENTA


title: 1BJZ02031305_fetallung

description: fetallung


title: MGMH030212067Amammarygland(lact)

description: mammary gland ; females with E18 embryos


title: 1BJZ02052324_FETALTHYROID

description: FETALTHYROID


title: MGJZ030312066Bplacenta

description: placenta; females with E18 embryos


title: 1BMH02022704_Thyroid

description: Thyroid


title: MGMH030312028Askeletalmuscle

description: skeletal muscle


title: MGMH030212067Bmammarygland(lact)


title: 1BJZ02060602_CardiacMyocytes

description: CardiacMyocytes


title: MGMH030228090Ablastocysts

description: blastocysts


title: MGMH030228090Bblastocysts

description: blastocysts


title: MGMH030312028Bskeletalmuscle

description: skeletal muscle


title: 1BMH02022104_thyroid

description: thyroid


title: MGJZ030207054Bheart

description: heart


title: 1BMH02022809_Uterus

description: Uterus


title: MGJZ030312066Aplacenta

description: placenta; females with E18 embryos


title: MGJZ030312082Acd8+Tcell


title: 1BMH02030601_Prostate

description: Prostate


title: MGMH030212061Abrownfat

description: brown fat; interscapular depression


title: MGJZ030207054Aheart

description: heart


title: MGJZ030312082Bcd8+Tcell


title: 1BMH02022804_Prostate

description: Prostate


title: 1BMH02022803_Uterus

description: Uterus


title: MGMH030212061Bbrownfat

description: brown fat; interscapular depression


title: 1BJZ02022644_kidney

description: kidney


title: MGJZ030312081Acd4+Tcell


title: MGJZ030312083Bb220+bcell


title: 1BMH02022812_Liver

description: Liver


title: MGJZ030312081Bcd4+Tcell


title: 1BJZ02030684_KIDNEY

description: KIDNEY


title: 1BMH02022811_Lung

description: Lung


title: 1BMH02022806_Liver

description: Liver


title: 1BMH02022805_Lung

description: Lung


title: 1BMH02022802_Heart

description: Heart


title: 1BMH02022808_Heart

description: Heart


title: 1BJZ02022646_adrenalgland

description: adrenalgland


title: 1BJZ02022112_fetalbrain

description: fetalbrain


title: 1BJZ02022761_adrenalgland

description: adrenalgland


title: MGJZ030312083Ab220+bcell


title: 1BJZ02022227_fetalbrain

description: fetalbrain


title: MGMH030311036Athymus

description: thymus


title: 1BJZ02022108_spinalcord

description: spinalcord


title: 1BJZ02022223_spinalcord

description: spinalcord


title: MGJZ030228017Blargeintestine

description: large intestine; cecum


title: MGJZ030228005Bbone

description: bone; femur


title: MGMH030312056Bbonemarrow

description: bone marrow; flushed from femur


title: MGMH030312056Abonemarrow

description: bone marrow; flushed from femur


title: 1BJZ02081480a_Pons

description: Pons


title: 1BJZ02081480b_Pons

description: Pons


title: MGJZ030228033Aspleen

description: spleen


title: MGMH030212052Astomach

description: stomach


title: MGJZ030228033Bspleen

description: spleen


title: MGJZ030228005Abone

description: bone; femur


title: MGJZ030212069Aumbilicalcord

description: umbilical cord; E18 embryos


title: MGJZ030228017Alargeintestine

description: large intestine; cecum


title: MGJZ030212069Bumbilicalcord

description: umbilical cord; E18 embryos


title: MGMH030212052Bstomach

description: stomach


title: 1BJZ02060408_CingulateCortex

description: CingulateCortex


title: 1BJZ02060505_CingulateCortex

description: CingulateCortex


title: MGJZ030228092Bvomeralnasalorgan(VMO)

description: vomeral nasal organ


title: 1BRS02080877a_subthalamic_nucleus


title: MGMH030211019Alung

description: lung


title: MGJZ030212025Bprostate

description: prostate


title: 1BJZ02021377_brainThalamus

description: brainThalamus


title: 1BJZ02072563_Hypothalamus

description: Hypothalamus


title: 1BJZ02040818_brainThalamus

description: brainThalamus


title: MGJZ030212025Aprostate

description: prostate


title: 1BRS02080877b_subthalamic_nucleus


title: MGJZ030228093Bmedialolfactoryepithelium(MOE)

description: main olfactory epithelium


title: MGMH030211019Blung

description: lung


title: MGJZ030402093Amedialolfactoryepithelium(MOE)

description: main olfactory epithelium


title: MGJZ030228092Avomeralnasalorgan(VMO)

description: vomeral nasal organ


title: 1BJZ02060406_Hypothalamus

description: Hypothalamus


title: 1BJZ02051610_OccipitalLobe

description: OccipitalLobe


title: MGMH030311038Btongueepidermis

description: tongue epidermis; dorsal tongue surface


title: 1BMH02022705_Brain Amygdala

description: Brain Amygdala

source_name: 1BMH02022705_Brain Amygdala

tag: 1BMH02022705_Brain Amygdala


title: 1BJZ02051609_OccipitalLobe

description: OccipitalLobe


title: 1BJZ02053112_PrefrontalCortex

description: PrefrontalCortex


title: 1BJZ02053110_PrefrontalCortex

description: PrefrontalCortex


title: 1BJZ02081479b_Medulla_Oblongata


title: MGMH030311030Asnoutepidermis

description: snout epidermis; vibrissa epidermal region


title: MGMH030311010Bdigits

description: digits


title: MGMH030311010Adigits

description: digits


title: MGJZ030212055Bepidermis

description: epidermis; dorsal skin without fur


title: 1BJZ02051614_ParietalLobe

description: ParietalLobe


title: 1BJZ02081479a_Medulla_Oblongata


title: MGMH030311038Atongueepidermis

description: tongue epidermis; dorsal tongue surface


title: MGMH030311030Bsnoutepidermis


title: 1BMH02022105_Brain Amygdala

description: Brain Amygdala

source_name: 1BMH02022105_Brain Amygdala

tag: 1BMH02022105_Brain Amygdala


title: 1BMH02022807_Whole Brain

description: Whole Brain

source_name: 1BMH02022807_Whole Brain

tag: 1BMH02022807_Whole Brain


title: MGMH030401084Bembryoday6.5

description: embryo day 6.5


title: 1BMH02022801_Whole Brain

description: Whole Brain

source_name: 1BMH02022801_Whole Brain

tag: 1BMH02022801_Whole Brain


title: 1BJZ02061908_caudatenucleus

description: caudatenucleus


title: 1BJZ02051613_ParietalLobe

description: ParietalLobe


title: MGJZ030212055Aepidermis

description: epidermis; dorsal skin without fur


title: 1BJZ02061808_caudatenucleus

description: caudatenucleus


title: MGMH030228085Bembryoday7.5

description: embryo day 7.5


title: 1BJZ02022763_cerebellum

description: cerebellum


title: MGMH030228087Bembryoday9.5

description: embryo day 9.5


title: MGMH030228084Aembryoday6.5

description: embryo day 6.5


title: MGMH030228085Aembryoday7.5

description: embryo day 7.5


title: 1BJZ02022648_cerebellum

description: cerebellum


title: MGMH030228086Bembryoday8.5

description: embryo day 8.5


title: MGMH030228086Aembryoday8.5

description: embryo day 8.5


title: MGMH030228087Aembryoday9.5

description: embryo day 9.5


title: 1BJZ02051612_CerebellumPeduncles

description: CerebellumPeduncles


title: 1BJZ02051611_CerebellumPeduncles

description: CerebellumPeduncles


title: 1BRS02080874a_globus_pallidus


title: 1BRS02080874b_globus_pallidus


title: 1BJZ02081484b_TemporalLobe

description: TemporalLobe


title: 1BJZ02081484a_TemporalLobe

description: TemporalLobe


title: MGJZ030211004Abladder

description: bladder


title: MGMH030228091Aembryoday10.5

description: embryo day 10.5


title: MGMH030228091Bembryoday10.5

description: embryo day 10.5


title: 1BJZ02030473_bonemarrow

description: bonemarrow


title: 20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder

description: breast tumor biopsy


title: MGJZ030211002Badrenalgland

description: adrenal gland


title: MGJZ030211004Bbladder

description: bladder


title: MGJZ030211002Aadrenalgland

description: adrenal gland


title: MGJZ030211001Aadiposetissue

description: adipose tissue; mesenteric


title: 1BMH02083001_BM_CD71EarlyErythroid

description: bone marrow-CD71EarlyErythroid


title: 1BJZ02022749_fetalliver

description: fetalliver


title: 1BMH02083002_BM_CD71EarlyErythroid

description: bone marrow-CD71EarlyErythroid


title: 1BJZ02022866_bonemarrow

description: bonemarrow


title: MGJZ030211001Badiposetissue

description: adipose tissue; mesenteric


title: MGJZ030207041Buterus

description: uterus


title: 1BJZ02022634_fetalliver

description: fetalliver


title: 1BJZ02022116_lymphnode

description: lymphnode


title: 1BJZ02022231_lymphnode

description: lymphnode


title: 1BJZ02052115_Tonsil

description: Tonsil


title: MGMH030312023Bovary

description: ovary


title: MGMH030311039Atrachea

description: trachea


title: MGMH030311039Btrachea

description: trachea


title: 1BJZ02022757_thymus

description: thymus


title: 1BJZ02051716_Tonsil

description: Tonsil


title: MGMH030211026Aretina

description: retina


title: 1BJZ02022642_thymus

description: thymus


title: MGJZ030207041Auterus

description: uterus


title: 1BJZ02022106_leukemiachronicmyelogenous(k562)


title: 1BJZ02022221_leukemiachronicmyelogenous(k562)


title: 1BJZ02022219_leukemiapromyelocytic(hl60)


title: MGMH030312023Aovary

description: ovary


title: 1BJZ02031098_lymphomaburkittsDaudi

description: lymphomaburkittsDaudi


title: MGMH030211026Bretina

description: retina


title: 1BJZ02031303_lymphomaburkittsDaudi

description: lymphomaburkittsDaudi


title: MGJZ030207020Alymphnode

description: lymphnode; mesenteric


title: MGJZ030207020Blymphnode

description: lymphnode; mesenteric


title: 1BJZ02022104_leukemiapromyelocytic(hl60)


title: 1BMH02022103_LymphomaRaji

description: LymphomaRaji


title: MGJZ030312065Bdorsalrootganglion

description: dorsal root ganglion


title: MGJZ030228080Bpituitary

description: pituitary


title: MGJZ030312065Adorsalrootganglion

description: dorsal root ganglion


title: MGMH030212040Btrigeminal

description: trigeminal


title: MGJZ030228080Apituitary

description: pituitary


title: MGMH030212040Atrigeminal

description: trigeminal


title: 1BMH02083009_721_Blymphoblasts


title: 1BJZ02030679_LEUKEMIALYMPHOBLASTIC(MOLT4)


title: 1BMH02020805_LymphomaRaji

description: LymphomaRaji


title: 1BMH02082902_BM_CD34

description: bone marrow-CD34


title: MGJZ030212070Bolfactorybulb

description: olfactory bulb


title: 1BMH02082901_BM_CD34

description: bone marrow-CD34


title: 1BMH02082903_BM_CD105endothelial

description: bone marrow-CD105endothelial


title: MGMH030211062Bamygdala

description: amygdala


title: MGJZ030212070Aolfactorybulb

description: olfactory bulb


title: 1BJZ02022102_leukemialymphoblastic(molt4)


title: MGMH030312008Acortex

description: cerebral cortex


title: MGJZ030207007Acerebellum

description: cerebellum


title: 1BMH02083005_PB_CD8TCells

description: peripheral blood-CD8TCells


title: MGJZ030211071Adorsalstriatum

description: dorsal striatum; above anterior commisure, approximately Bregma 1.3 to -0.3


title: 1BMH02083010_721_Blymphoblasts


title: MGJZ030212014Ahippocampus

description: hippocampus


title: MGJZ030207007Bcerebellum

description: cerebellum


title: MGJZ030212009Bfrontalcortex

description: frontal cortex


title: 1BMH02082908_PB_CD19BCells

description: peripheral blood-CD19BCells


title: MGJZ030212014Bhippocampus

description: hippocampus


title: MGJZ030211071Bdorsalstriatum


title: MGJZ030212009Afrontalcortex

description: frontal cortex


title: MGJZ030212008Bcerebralcortex

description: cerebral cortex; minus frontal


title: 1BMH02083007_PB_CD4TCells

description: peripheral blood-CD4TCells


title: MGMH030402094Bpreoptic

description: preoptic


title: 1BMH02082907_PB_CD19BCells

description: peripheral blood-CD19BCells


title: 1BMH02082910_PB_CD56NKCells

description: peripheral blood-CD56NKCells


title: 1BMH02083006_PB_CD8TCells

description: peripheral blood-CD8TCells


title: MGMH030211062Aamygdala

description: amygdala; approximately Bregma -1.1 to -2.1


title: 1BMH02082904_BM_CD105endothelia

description: bone marrow-CD105endothelia


title: 1BMH02082911_PB_BDCA4DendriticCells

description: peripheral blood-BDCA4DendriticCells


title: MGMH030401094Apreoptic

description: preoptic


title: MGMH030212053Ahypothalamus

description: hypothalamus


title: 1BMH02083003_PB_CD14Monocytes

description: peripheral blood-CD14Monocytes


title: 1BMH02083008_PB_CD4TCells

description: peripheral blood-CD4TCells


title: 1BMH02082909_PB_CD56NKCells

description: peripheral blood-CD56NKCells


title: 1BMH02082912_PB_BDCA4DendriticCells

description: peripheral blood-BDCA4DendriticCells


title: 1BMH02082906_BM_CD33myeloid

description: bone marrow-CD33myeloid


title: 1BJZ02052319_WHOLEBLOOD(JJV)

description: WHOLEBLOOD(JJV)


title: 1BJZ02052321_WHOLEBLOOD(JJV)

description: WHOLEBLOOD(JJV)


title: 1BMH02082905_BM_CD33myeloid

description: bone marrow-CD33myeloid


title: MGMH030212058Aspinalcordupper

description: spinal cord upper; upper half


title: MGMH030212058Bspinalcordupper

description: spinal cord upper; upper half


title: MGMH030212057Bspinalcordlower

description: spinal cord lower; lower half


title: MGMH030212057Aspinalcordlower

description: spinal cord lower; lower half


title: MGJZ030212072Bsubstantianigra

description: substantia nigra


title: MGJZ030212072Asubstantianigra

description: substantia nigra


title: MGMH030212053Bhypothalamus

description: hypothalamus


title: 1BMH02083004_PB_CD14Monocytes

description: peripheral blood-CD14Monocytes


title: 1BMH02022701_Colorectal Adenocarc

description: Colorectal Adenocarc

source_name: 1BMH02022701_Colorectal Adenocarc

tag: 1BMH02022701_Colorectal Adenocarc


title: 1BMH02022101_Colorectal Adenocarc

description: Colorectal Adenocarc

source_name: 1BMH02022101_Colorectal Adenocarc

tag: 1BMH02022101_Colorectal Adenocarc


title: cornea Sprague1

status: Public on Jan 27 2004

description:
cornea Sprague1
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley cornea
file:R3RS01112801

organism: Rattus norvegicus


title: primary cortical neurons sprague2

description:
primary cortical neurons sprague2
pool of several animals, 16 days gestation, unknown gender
Sprague Dawley primary cortical neurons
file:R3RS01062216


title: dorsal raphe sprague1

description:
dorsal raphe sprague1
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley dorsal raphe nucleus
file:R3MH02060701


title: primary cortical neurons sprague1

description:
primary cortical neurons sprague1
pool of several animals, 16 days gestation, unknown gender
Sprague Dawley primary cortical neurons
file:R3RS01062111


title: prefrontal cortex sprague2

description:
prefrontal cortex sprague2
whole tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley prefrontal cortex
file:R3MH02052402


title: hypothalamus sprague1

description:
hypothalamus sprague1
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley hypothalamus
file:R3MH02061102


title: locus coeruleus sprague2

description:
locus coeruleus sprague2
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley locus coeruleus
file:R3MH02051602


title: hypothalamus sprague2

description:
hypothalamus sprague2
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley hypothalamus
file:R3MH02061201


title: dorsal raphe sprague2

description:
dorsal raphe sprague2
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley dorsal raphe nucleus
file:R3MH02060702


title: amygdala, central nucleus sprague1

description:
amygdala, central nucleus sprague1
whole tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley amygdala, central nucleus
file:R3KJF02021179


title: prefrontal cortex sprague1

description:
prefrontal cortex sprague1
whole tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley prefrontal cortex
file:R3MH02052401


title: ventral tegmental area sprague1

description:
ventral tegmental area sprague1
obtained with a 16 gauge punch from coronal brain slices from 5.0-6.3 mm posterior to bregma, pool of 5 animals, 16 weeks old, male
Sprague Dawley ventral tegmental area
file:R3KJF02012263


title: nucleus accumbens_shell sprague2

description:
nucleus accumbens_shell sprague2
Half-moon-shaped NAc shell samples were obtained with a 12 gauge punch of the remaining ventromedial shell tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley nucleus accumbens shell
file:R3MH01112101


title: amygdala, central nucleus sprague2

description:
amygdala, central nucleus sprague2
whole tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley amygdala, central nucleus
file:R3KJF02021180


title: nucleus accumbens_shell sprague1

description:
nucleus accumbens_shell sprague1
Half-moon-shaped NAc shell samples were obtained with a 12 gauge punch of the remaining ventromedial shell tissue, pool of 5 animals, 20 weeks old, male
Sprague Dawley nucleus accumbens shell
file:R3MH01110601


title: dorsal striatum sprague 3978

description:
dorsal striatum sprague 3978
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley dorsal striatum
file:R3MH01022301


title: endothelial cells sprague2

description:
endothelial cells sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley endothelial cells
file:R3JW02103022


title: ventral tegmental area sprague2

description:
ventral tegmental area sprague2
obtained with a 16 gauge punch from coronal brain slices from 5.0-6.3 mm posterior to bregma, pool of 5 animals, 16 weeks old, male
Sprague Dawley ventral tegmental area
file:R3KJF02012264


title: cornea Sprague2

description:
cornea Sprague2
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley cornea
file:R3RS01112802


title: locus coeruleus sprague1

description:
locus coeruleus sprague1
whole tissue, pool of 5 animals, 16 weeks old, male
Sprague Dawley locus coeruleus
file:R3MH02051601


title: endothelial cells sprague1

description:
endothelial cells sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley endothelial cells
file:R3JW02103021


title: thymus sprague1

description:
thymus sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley thymus
file:R3JW02103017


title: dorsal striatum sprague 3981

description:
dorsal striatum sprague 3981
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley dorsal striatum
file:R3MH01022302


title: spleen sprague2

description:
spleen sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley spleen
file:R3JW02103016


title: large intestine sprague2

description:
large intestine sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley large intestine
file:R3JW02103014


title: heart sprague2

description:
heart sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley heart
file:R3JW02103012


title: heart sprague1

description:
heart sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley heart
file:R3JW02103011


title: spleen sprague1

description:
spleen sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley spleen
file:R3JW02103015


title: large intestine sprague1

description:
large intestine sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley large intestine
file:R3JW02103013


title: kidney sprague2

description:
kidney sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley kidney
file:R3JW02103008


title: thymus sprague2

description:
thymus sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley thymus
file:R3JW02103018


title: bone marrow sprague2

description:
bone marrow sprague2
whole tissue, pool of 5 animals, 10 weeks old, male
Sprague Dawley bone marrow
file:R3JW02103006


title: bone marrow sprague1

description:
bone marrow sprague1
whole tissue, pool of 5 animals, 10 weeks old, male
Sprague Dawley bone marrow
file:R3JW02103005


title: skeletal muscle sprague2

description:
skeletal muscle sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley skeletal muscle
file:R3JW02103004


title: skeletal muscle sprague1

description:
skeletal muscle sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley skeletal muscle
file:R3JW02103003


title: dorsal root ganglion fisher2

description:
dorsal root ganglion fisher2
whole tissue, pool of 5 animals, 16 weeks old, male
Fisher dorsal root ganglion
file:p3972w


title: dorsal striatum wistar ky 3970

description:
dorsal striatum wistar ky 3970
whole tissue, individual animal, 10 weeks old, male
Wistar Kyoto dorsal striatum
file:p3966w


title: dorsal root ganglion fisher1

description:
dorsal root ganglion fisher1
whole tissue, pool of 5 animals, 16 weeks old, male
Fisher dorsal root ganglion
file:p3970w


title: kidney sprague1

description:
kidney sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley kidney
file:R3JW02103007


title: pineal sprague2

description:
pineal sprague2
whole tissue, pool of 5 animals, 10 weeks old, male
Sprague Dawley pineal
file:R3JBH02100402


title: dorsal striatum wistar ky 3972

description:
dorsal striatum wistar ky 3972
whole tissue, individual animal, 10 weeks old, male
Wistar Kyoto dorsal striatum
file:p3978w


title: ventral striatum sprague 3962

description:
ventral striatum sprague 3962
freehand block dissections, removed only cortex, individual animal, 10 weeks old, male
Sprague Dawley ventral striatum
file:p3962w


title: small intestine sprague1

description:
small intestine sprague1
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley small intestine
file:R3JW02103001


title: dorsal striatum wistar 3966

description:
dorsal striatum wistar 3966
whole tissue, individual animal, 10 weeks old, male
Wistar dorsal striatum
file:p3981w


title: nucleus accumbens, whole wistar2

description:
nucleus accumbens, whole wistar2
Obtained with a 1.5 mm diameter punch, using a 2mm thick slice, and anterior commisure was in dorsolateral portion of punch.
Wistar whole nucleus accumbens
file:R3JV01080106


title: nucleus accumbens_core sprague1

description:
nucleus accumbens_core sprague1
Obtained with a 14 gauge punch from chilled coronal brain slices (0.7-2.2 mm anterior to bregma; Paxinos and Watson, 1998; pool of 5 animals, 20 weeks old, male
Sprague Dawley nucleus accumbens core
file:R3JV01080107


title: ventral striatum wistar 4026

description:
ventral striatum wistar 4026
freehand block dissections, removed only cortex, individual animal, 10 weeks old, male
Wistar ventral striatum
file:p4026w


title: small intestine sprague2

description:
small intestine sprague2
whole tissue, individual animal, 10 weeks old, male
Sprague Dawley small intestine
file:R3JW02103002


title: ventral striatum wistar ky 3959

description:
ventral striatum wistar ky 3959
freehand block dissections, removed only cortex, individual animal, 10 weeks old, male
Wistar Kyoto ventral striatum
file:p3959w


title: ventral striatum sprague 3961

description:
ventral striatum sprague 3961
freehand block dissections, removed only cortex, individual animal, 10 weeks old, male
Sprague Dawley ventral striatum
file:p3961w